Search Results - "FRENAIS, R"

Pharmacokinetics of controlled-release carbimazole tablets support once daily dosing in cats by FRÉNAIS, R, BURGAUD, S, HORSPOOL, L.J.I

“…Carbimazole, a prodrug of methimazole, is used in the treatment of hyperthyroidism in cats. The pharmacokinetics of methimazole was investigated in healthy…”
Get full text

Colonic fermentation of inulin increases whole-body acetate turnover in dogs by Pouteau, E, Frenais, R, Dumon, H, Noah, L, Martin, L, Nguyen, P

“…Metabolism of acetate from colonic fermentation was investigated in dogs. Beagle dogs (n = 9) were fed a control diet for 17 d followed by a 3% inulin-enriched…”
Get more information

Apolipoprotein A-I kinetics in heterozygous familial hypercholesterolemia: a stable isotope study by Frénais, R, Ouguerram, K, Maugeais, C, Marchini, J S, Benlian, P, Bard, J M, Magot, T, Krempf, M

“…Heterozygous familial hypercholesterolemia (FH) is associated with a moderate decrease of plasma apoA-I and HDL-cholesterol levels. The aim of the study was to…”
Get full text

Clinical efficacy and safety of a once-daily formulation of carbimazole in cats with hyperthyroidism by Frénais, R, Rosenberg, D, Burgaud, S, Horspool, L.J.I

“…Evaluation of efficacy and safety of a novel controlled-release formulation of carbimazole in feline hyperthyroidism. A multicentre, self-controlled study in…”
Get full text

In vivo evidence for the role of lipoprotein lipase activity in the regulation of apolipoprotein AI metabolism : A kinetic study in control subjects and patients with type II diabetes mellitus by FRENAIS, R, NAZIH, H, OUGUERRAM, K, MAUGEAIS, C, ZAÏR, Y, BARD, J. M, CHARBONNEL, B, MAGOT, T, KREMPF, M

“…The aim of this study was to delineate the role of lipoprotein lipase (LPL) activity in the kinetic alterations of high density lipoprotein (HDL) metabolism in…”
Get full text

Influence of atorvastatin on apolipoprotein E and AI kinetics in patients with type 2 diabetes by Bach-Ngohou, K, Ouguerram, K, Frénais, R, Maugère, P, Ripolles-Piquer, B, Zaïr, Y, Krempf, M, Bard, J M

“…Atorvastatin reduces both plasma cholesterol and triglyceride concentrations in patients with type 2 diabetes, but mechanisms underlying triglyceride decrease…”
Get more information

Effect of dietary omega-3 fatty acids on high-density lipoprotein apolipoprotein AI kinetics in type II diabetes mellitus by Frénais, R, Ouguerram, K, Maugeais, C, Mahot, P, Charbonnel, B, Magot, T, Krempf, M

“…The effect of a dietary fish oil supplementation on metabolism of HDL was studied in type II diabetes mellitus. Endogenous labeling of HDL-apo AI was performed…”
Get full text

Apolipoprotein E kinetics: influence of insulin resistance and type 2 diabetes by Bach-Ngohou, K, Ouguerram, K, Nazih, H, Nazih, P, Maugère, P, Ripolles-Piquer, B, Zaïr, Y, Frénais, R, Krempf, M, Bard, J.M

“…BACKGROUNDS AND AIMS: Insulin resistance related to obesity and diabetes is characterized by an increase in plasma TG-rich lipoprotein concentrations…”
Get full text

High density lipoprotein apolipoprotein AI kinetics in NIDDM: a stable isotope study by Frénais, R, Ouguerram, K, Maugeais, C, Mahot, P, Maugère, P, Krempf, M, Magot, T

“…High density lipoprotein (HDL) kinetics were studied by infusing [5,5,5-2H3]-leucine in five subjects with normal glucose tolerance and eight patients with…”
Get full text

Effect of low-density lipoprotein apheresis on kinetics of apolipoprotein B in heterozygous familial hypercholesterolemia by MAUGEAIS, Cyrille, OUGUERRAM, Khadija, FRENAIS, Regis, MAUGERE, Pascale, CHARBONNEL, Bernard, MAGOT, Thierry, KREMPF, Michel

“…The acute reduction of low-density lipoprotein (LDL) cholesterol obtained by LDL-apheresis allows the role of the high level of circulating LDL on lipoprotein…”
Get full text

Effect of low-density lipoproteins on apolipoprotein AI kinetics in heterozygous familial hypercholesterolemia by Fr[eacute]nais, R., Maugeais, C., Ouguerram, K., Za[iuml ]r, Y., Bard, J.M., Charbonnel, B., Magot, T., Krempf, M.

“…In patients with heterozygous familial hypercholesterolemia (FH), both synthetic and clearance rates of high-density lipoproteins (HDL) are increased compared…”
Get full text

High density lipoprotein apolipoprotein Al kinetics in NIDDM : a stable isotope study by FRENAIS, R, OUGUERRAM, K, MAUGEAIS, C, MAHOT, P, MAUGERE, P, KREMPF, M, MAGOT, T

Get full text

Disorder of apolipoprotein AI metabolism in non insulin-dependent diabetes mellitus: a kinetic study by Frenais, R., Ouguerram, K., Maugeais, C., Mahot, P., Magot, T., Krempf, M.

Get full text

Altered apolipoprotein AI metabolism in subjects with type IIA heterozygous familial hypercholesterolemia: a kinetic study by Frénais, R., Maugeais, C., Ouguerram, K., De Mallmann, V., Magot, T., Bard, J. M., Krempf, M.

Get full text

In Vivo Evidence for the Role of Lipoprotein Lipase Activity in the Regulation of Apolipoprotein AI Metabolism: A Kinetic Study in Control Subjects and Patients with Type II Diabetes Mellitus 1 by Frénais, R., Nazih, H., Ouguerram, K., Maugeais, C., Zaïr, Y., Bard, J. M., Charbonnel, B., Magot, T., Krempf, M.

Get full text

In Vivo Evidence for the Role of Lipoprotein Lipase Activity in the Regulation of Apolipoprotein AI Metabolism: A Kinetic Study in Control Subjects and Patients with Type II Diabetes Mellitus1 by Frénais, R., Nazih, H., Ouguerram, K., Maugeais, C., Zaïr, Y., Bard, J. M., Charbonnel, B., Magot, T., Krempf, M.

“…The aim of this study was to delineate the role of lipoprotein lipase (LPL) activity in the kinetic alterations of high density lipoprotein (HDL) metabolism in…”
Get full text

Effects of lipoprotein lipase activity on HDL-apo AI metabolism in type II diabetes mellitus: A kinetic study by Frénais, R., Ouguerram, K., Nazih, H., Maugeais, C., Zaïr, Y., Magot, T., Krempf, M.

Get full text

4.P.256 Measurement of apo AI kinetics using stable isotopes in patients with heterozygous familial hypercholesterolemia by Frénais, R., Ouguerram, K., Maugeais, C., Trouvat, A.M., De Mallmann, V., Magot, T., Krempf, M.

Get full text